Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas [Phase 2]
Phase II open-label study of ixazomib (MLN9708) in relapsed/refractory cutaneous and peripheral T-cell lymphomas has completed with results …
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Phase I/II trial of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 2]
This entry describes a Phase 2 clinical trial evaluating chidamide in combination with the PECM regimen for relapsed or refractory periphera…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) [NA]
A clinical trial investigating chidamide in combination with CHOP for newly diagnosed peripheral T cell lymphoma; current status is unknown.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: T-Cell Project: Epidemiologic Component
Update on the completion of the epidemiologic component of the National Cancer Institute's T-Cell Project studying Peripheral T-Cell Lymphom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
Update on a completed clinical trial evaluating biomarkers in tumor tissue from patients with Peripheral T-cell lymphoma or natural killer c…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy [Phase 4]
Clinical trial update describing a Phase 4 study of pralatrexate in Asian patients with peripheral T-cell lymphoma after prior therapy.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients [Phase 1, Phase 2]
This document reports the completion of a Phase I/II clinical study evaluating forodesine in Japanese patients with recurrent or refractory …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of oral clofarabine in relapsed/refractory non-Hodgkin lymphoma completed with posted results.
-
FDA approval · 2017-04-12FDA Approved: BELEODAQ — Supplemental Application (Acrotech Biopharma Inc)
FDA approved a supplemental application for Beleodaq (belinostat) submitted by Acrotech Biopharma Inc.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results po…
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas
This clinical trial explores whether monocyte subpopulations can predict prognosis in lymphomas, including diffuse large B-cell lymphoma. It…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
The trial update examines circulating tumor DNA as a biomarker to predict relapse and overall survival in non-Hodgkin lymphoma patients, inc…
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
This clinical trial update reports a retrospective analysis of clinical, phenotypic, and genetic factors in peripheral T-cell lymphomas. The…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma [Phase 2]
Phase 2 trial of mogamulizumab (KW-0761) for CCR4-positive Peripheral T/NK-cell lymphoma has completed.
-
CLINICAL_TRIALS research · 2017-02-13Clinical Trial Update: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma [NA]
This entry reports an ongoing clinical trial evaluating an 18F-FDG PET/CT–based prognostic model to predict outcomes in patients with periph…
-
CLINICAL_TRIALS research · 2017-02-13Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma [NA]
This clinical trial update describes evaluating liver SUVmax-based criteria on 18F-FDG PET/CT to predict prognosis in patients with Peripher…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas [Phase 1]
Phase 1 study evaluating CHOP chemotherapy plus Campath-1H (alemtuzumab) as initial treatment for untreated aggressive T/NK-cell non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 [NA]
A pilot study of Brentuximab Vedotin in relapsed/refractory CD30-positive Peripheral T-Cell Lymphoma was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients [Phase 3]
Phase 3 clinical trial update comparing the CDOP chemotherapy regimen alone versus CDOP combined with chidamide in de novo Peripheral T-Cell…
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating chidamide with CHOEP chemotherapy and upfront autologous stem cell transplant in untreated peripheral …
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL [Phase 1]
This update reports the withdrawal of a Phase 1 study evaluating volasertib plus romidepsin for relapsed/refractory peripheral T-cell lympho…
-
CLINICAL_TRIALS research · 2016-10-26Clinical Trial Update: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating chidamide for refractory or relapsed peripheral T cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Treatment of Peripheral T-cell Lymphoma [Phase 4]
Phase 4 clinical trial update on the treatment of Peripheral T-cell Lymphoma. The study has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 trial evaluating romidepsin for peripheral T-cell lymphoma, including efficacy, safety, a…